Tea is an infusion of the leaves of the Camellia sinensis plant and is the most widely consumed beverage in the world, aside from water.1 Herbal teas are infusions of herbs or plants other than Camellia sinensis and will not be discussed in this article. Although tea contains several bioactive chemicals, including caffeine and fluoride, scientists are particularly interested in the potential health benefits of a class of compounds in tea known as flavonoids. In many cultures, tea is an important source of dietary flavonoids.
All teas are derived from the leaves of Camellia sinensis, but different processing methods produce different types of tea. Fresh tea leaves are rich in flavonoids known as catechins (Fig. 7.1). Tea leaves also contain polyphenol oxidase enzymes in separate compartments from catechins. When tea leaves are intentionally broken or rolled during processing, contact with polyphenol oxidase causes catechins to join together, forming dimers and polymers known as theaflavins (Fig. 7.2) and thearubigins, respectively. This oxidation process is known (incorrectly) in the tea industry as “fermentation.” Steaming or firing tea leaves inactivates polyphenol oxidase and stops the oxidation process.2 Although there are thousands of tea varieties, teas may be divided into three groups based on the amount of oxidation they undergo during processing.
Fig. 7.1 Chemical structures of the principal catechins in tea.
Fig. 7.2 Chemical structures of some theaflavins in tea.
White tea is made from buds and young leaves, which are steamed or fired to inactivate polyphenol oxidase, and then dried. Thus, due to minimal oxidation, white tea retains the high concentrations of catechins present in fresh tea leaves. Green tea is made from more mature tea leaves than white tea, and tea leaves may be withered prior to steaming or firing. Although they are also rich in catechins, green teas may have catechin profiles that are different from those of white teas, with slightly higher levels of oxidation products.3
Tea leaves destined to become oolong teas are “bruised” to allow the release of some of the polyphenol oxidase present in the leaves. Oolong teas are allowed to oxidize to a greater extent than white or green teas, but for less time than black teas, before they are heated and dried. Consequently, the catechin, theaflavin, and thearubigin levels in oolong teas are generally between those of green/white teas and completely oxidized black teas.2
Tea leaves that are destined to become black tea are fully rolled or broken to maximize the interaction between catechins and polyphenol oxidase. Because they are allowed to oxidize completely before drying, most black teas are rich in theaflavins and thearubigins, but relatively low in monomeric catechins, such as epigallocatechin gallate (EGCG).4
The definition of a cup of tea varies in different countries or regions. In Japan, a typical cup of green tea may contain only 100 mL (3.5 oz). A traditional European teacup holds approximately 125–150 mL (5 oz), while a mug of tea may contain 235 mL (8 oz) or more.
Table 7.1 Caffeine content of teas and coffee5,6
Type of Tea/Coffee |
Caffeine (mg/L) |
Caffeine (mg/8 oz) |
Green |
40–211 |
9–50 |
Black |
177–303 |
42–72 |
Coffee, brewed |
306–553 |
72–130 |
Table 7.2 Fluoride content of teas12
Type of Tea |
Fluoride (mg/L)a |
Fluoride (mg/8 oz) |
Green |
1.2–1.7 |
0.3–0.4 |
Oolong |
0.6–1.0 |
0.1–0.2 |
Black |
1.0–1.9 |
0.2–0.5 |
Brick tea |
2.2–7.3 |
0.5–1.7 |
a Fluoride in 1% w/v tea prepared by continuous infusion from 5 to 360 minutes.
Flavanols are the most abundant class of flavonoids in all types of tea. Flavanol monomers are also known as catechins. The principal catechins found in white and green tea are epicatechin (EC), epigallocatechin (EGC), epicatechin gallate (ECG), and epigallocatechin gallate (EGCG) (Fig. 7.1).2 In oolong and black teas, theaflavins (Fig. 7.2) and thearubigins are more abundant. Tea is also a good source of another class of flavonoids called flavonols. Flavonols found in tea include kaempferol, quercetin, and myricetin. The flavonol content of tea is minimally affected by processing, and flavonols are present in comparable quantities in all teas. Unlike flavanols, flavonols are usually present in tea as glycosides (bound to a sugar molecule).
All teas contain caffeine, unless they are deliberately decaffeinated during processing. The caffeine content of different varieties of tea may vary considerably and is influenced by factors like brewing time, the amount of tea and water used for brewing, and whether the tea is loose or in teabags. In general, a mug of tea contains about half as much caffeine as a mug of coffee.4 The caffeine contents of more than 20 green and black teas prepared according to package directions are presented in Table 7.1.5 The caffeine content of oolong teas is comparable to green teas.3 There is little information on the caffeine content of white teas, since they are often grouped together with green teas. Buds and young tea leaves have been found to contain higher levels of caffeine than older leaves,8 suggesting that the caffeine content of some white teas may be slightly higher than that of green teas.3 See Chapter 6 on Coffee for more information on caffeine.
Tea plants accumulate fluoride in their leaves. In general, the oldest tea leaves contain the most fluoride.9 Most high-quality teas are made from the bud or the first two to four leaves—the youngest leaves on the plant. Brick tea, a lower quality tea, is made from the oldest tea leaves and is often very high in fluoride. Symptoms of fluoride excess (i.e., dental and skeletal fluorosis) have been observed in Tibetan children and adults who consume large amounts of brick tea.10,11 Unlike brick tea, fluoride levels in green, oolong, and black teas are generally comparable to those recommended for the prevention of dental caries (cavities). Thus, daily consumption of up to 1 L of green, oolong, or black tea would be unlikely to result in fluoride intakes higher than those recommended for dental health.12,13 The fluoride content of white tea is likely to be less than that of other teas, since white teas are made from the buds and youngest leaves of the tea plant. The fluoride contents of 17 brands of green, oolong, and black teas are presented in Table 7.2.12 These values do not include the fluoride content of the water used to make the tea.
Many epidemiological studies have examined associations between tea consumption and manifestations of cardiovascular disease, including myocardial infarction (MI) and stroke. A meta-analysis that combined the results of ten prospective cohort studies and seven case–control studies found that a 24-oz increase in daily tea consumption was associated with an 11% decrease in the risk of MI.14 However, caution was urged in the interpretation of these results because of bias toward the publication of studies suggesting a protective effect. Since then, the results of several other prospective cohort studies have been mixed. A 6-year study of Dutch men and women found that those who drank at least three cups (approx. 13 oz) daily had a significantly lower risk of MI than those who did not drink tea.15 A 7-year study of US women found that the risk of important vascular events (MI, stroke, or death from cardiovascular disease) was significantly lower in a small number of women who drank at least four cups of black tea daily.16 However, the sample size in this group was very limited and thus the significance of this finding is unclear. A 15-year study of US men found no association between tea consumption and cardiovascular disease risk, but tea consumption in this population was relatively low, averaging one cup per day.17 Overall, the available research suggests that consumption of at least three cups per day of black tea may be associated with a modest decrease in the risk of MI. A recent prospective cohort study in 40 530 Japanese adults reported that green tea consumption was associated with reductions in all-cause mortality and cardiovascular-related mortality.18 Specifically, when compared with drinking less than one cup per day, consumption of up to five cups of green tea daily was associated with a 16% reduction in mortality from all causes and a 26% reduction in mortality from cardiovascular diseases. Both relationships were stronger in women than in men, and among types of cardiovascular diseases, the inverse association was strongest for stroke mortality.18 Thus, green tea may also protect against the development of cardiovascular diseases, but more research is necessary to draw any firm conclusions.
Vascular endothelial cells play an important role in maintaining cardiovascular health by producing nitric oxide, a compound that promotes arterial relaxation (vasodilation).19 Arterial vasodilation resulting from endothelial production of nitric oxide is termed endothelium-dependent vasodilation. Two controlled clinical trials found that the daily consumption of four to five cups (900–1250 mL) of black tea for four weeks significantly improved endothelium-dependent vasodilation in patients with coronary artery disease20 and in patients with mildly elevated serum cholesterol levels21 compared with the equivalent amount of hot water. One of these studies noted that caffeine, provided at an equivalent dose to that of tea, had no short-term effects on endothelium-dependent vasodilation, suggesting that noncaffeine components of black tea may be responsible for the reported short-term vasodilatory effects. Indeed, flavonoids contained in tea may exert such effects.22 See Chapter 11 for more information on Flavonoids. Several small studies have suggested that green tea, or its major catechin, EGCG, may have similar vasodilatory effects.23–25 The beneficial effect of tea consumption on vascular endothelial function could help explain the modest reduction in cardiovascular disease risk observed in some epidemiological studies.
Green and black tea have been found to have cancer-preventive activity in a variety of animal models of cancer, including cancer of the skin, lung, mouth, esophagus, stomach, colon, pancreas, bladder, and prostate.26,27 Additionally, white tea and green tea were shown to suppress intestinal polyps in mice. In most cases, flavonoids appear to contribute substantially to the cancer-preventing effects of tea, but caffeine has also been found to have cancer-preventing activity in some animal models of skin,28 lung,29 and colon30 cancer. Although the beneficial effects of tea flavonoids were often attributed to their antioxidant activity, the overall contribution of tea flavonoids to plasma and tissue antioxidant activity in humans is now thought to be relatively minor.31 Currently, scientists are focusing their attention on the potential for tea flavonoids to modulate cell-signaling pathways that promote the transformation of healthy cells to cancerous cells.32,33 See Chapter 11 for more information on flavonoids.
Despite promising results from animal studies, it is not clear whether increasing tea consumption will help prevent cancers in humans. The results of numerous epidemiological studies, focusing on many different types of cancers, do not provide any consistent evidence that consumption of green or black tea is associated with significant reductions in cancer risk.34 A recent prospective cohort study in 40 530 Japanese adults participating in the Ohsaki National Health Insurance Cohort Study reported that green tea consumption was not associated with total cancer mortality, or mortality from gastric, lung, or colorectal cancers.18 Because tea comes into direct contact with the gastrointestinal tract, scientists have been particularly interested in whether increased tea consumption may prevent cancers of the stomach and colon. Although a few case–control studies suggested that higher intakes of green tea were associated with decreased stomach cancer risk35–37, prospective cohort studies do not support an inverse association between green tea consumption and stomach cancer risk in Japanese men and women.38–42 Despite promising findings in animal models of colon cancer,43 the majority of epidemiological studies have not found tea consumption to be associated with lower risk for colorectal cancer.44,45 A meta-analysis of case–control and prospective studies concluded that currently available data do not suggest that either green or black tea is protective against colorectal cancer.46 More recently, a systematic review of 51 studies, including more than 1.6 million participants, concluded that there is no convincing evidence that green tea consumption prevents various types of cancer.47
There are several possible reasons for the discrepancies between findings from animal models of cancer and epidemiological studies in humans. Aside from potential species differences, it may be difficult for humans drinking tea to reach sufficient plasma and tissue levels of tea flavonoids to realize a protective effect. In general, flavonoids are rapidly metabolized and eliminated from the body, but there is considerable variation among individuals in this respect.48 Catechol-O- methyltransferase (COMT) is one of the enzymes involved in flavonoid metabolism. There are two forms of the gene for COMT—a low-activity form and a high-activity form. A case–control study found that higher intakes of green tea were associated with lower breast cancer risk only in women who had inherited at least one copy of the low-activity form of COMT, suggesting that those who are less efficient at eliminating green tea flavonoids may be more likely to benefit from their consumption.49 Relationships between tea consumption and cancer risk are likely to be complex, and further study is needed before specific recommendations can be made regarding tea consumption and cancer prevention.
Many factors can affect the development of osteoporosis, including nutrition, physical activity, and genetic factors. Components in tea, including caffeine, fluoride, and flavonoids, may influence bone mineral density (BMD).50 Although one cross-sectional study found that black tea consumption was associated with slightly lower BMD in US women,51 three other cross-sectional studies found that habitual tea consumption was associated with higher BMD in British52 and Canadian women53 and in Taiwanese men and women.50 A prospective study in 164 elderly women found that consumption of tea blunted the age-related loss in total-hip BMD.54 Hip fracture is one of the most serious consequences of osteoporosis. A large case–control study in Mediterranean countries found that low tea consumption was associated with higher risk of hip fracture in men55 and women.56 However, two large prospective cohort studies of US women found no relationship between tea consumption and the risk of hip or wrist fracture over 4–6 years of follow-up.57,58 The most recent of these two studies found that higher tea intakes were associated with slightly higher BMD in postmenopausal women, but this finding did not translate into a lower risk of hip or wrist fracture.57 Further study is required to determine whether tea consumption affects the development of osteoporosis or the risk of osteoporotic fracture in a meaningful way.
Fluoride concentrations in tea are comparable to those recommended for US water supplies to prevent dental caries (cavities).59 Green, black, and oolong tea extracts have been found to inhibit the growth and acid production of cavity-producing bacteria in the test tube.60–62 Although tea extracts reportedly prevent or decrease dental caries in animal models,63 few published studies have examined the effect of tea consumption on dental caries in humans. A cross-sectional study of more than 6000 14-year old children in the United Kingdom found that those who drank tea had significantly fewer dental caries than nondrinkers; results were independent of whether sugar was added to tea.64
Two large prospective studies found that the risk of developing symptomatic kidney stones decreased by 8% in women65 and 14% in men66 for each 8-oz (235 mL) mug of tea consumed daily. A study in rats concluded that the antioxidants in green tea may be involved in inhibiting calcium oxalate precipitation and thus kidney stone formation.67 The implications of these findings for individuals with a previous history of calcium oxalate stone formation are unclear. High fluid intake, including tea intake, is generally considered the most effective and economical means of preventing kidney stones.68 However, tea consumption has been found to increase urinary oxalate levels in healthy individuals,69 and some experts continue to advise people with a history of calcium oxalate stones to limit tea consumption.70
Weight reduction can be achieved by long-term decreases in energy intake and/or increases in energy expenditure. Several small short-term trials have reported modest 3%–4% increases in energy expenditure after the consumption of oolong tea71,72 or green tea extract.73 However, none of these studies was specifically designed to assess weight loss. More recently, a clinical trial in overweight men and women, who had lost an average of 7.5% of their body weight by adhering to a very low-calorie diet for 4 weeks, found that green tea capsules (containing 573 mg/day of catechins and 104 mg/day of caffeine) were no better than placebo in preventing weight regain over the next 8 weeks.74 A follow-up study by the same group of investigators reported that supplementation with green tea extract prevented weight regain after weight loss in subjects with low habitual caffeine intake (<300 mg/day) but not in those with high habitual caffeine intake (>300 mg/day).75 A recent 12-week intervention trial in 35 overweight men reported that those given oolong tea enriched with green tea extract (690 mg catechins/day) experienced significant reductions in body weight, body mass index (BMI), waist circumference, body fat mass, and subcutaneous fat area compared with those administered oolong tea (33 mg catechins/day).76 Large-scale intervention trials that control for energy intake and physical activity are needed to determine if tea or tea extracts promote weight loss or improve maintenance in humans. Interestingly, animal model studies showed a lowering of tissue fat levels in mice drinking green tea, black tea, or a caffeine-containing solution.28
Tea is generally considered to be safe, even in large amounts. However, two cases of hypokalemia (abnormally low serum potassium levels) in the elderly have been attributed to excessive consumption of black and oolong tea (3–14 L/day).77,78 Hypokalemia is a potentially life-threatening condition that has been associated with caffeine toxicity.
In clinical trials employing caffeinated green tea extracts, cancer patients who took 6 g/day, in three to six divided doses, experienced mild to moderate gastrointestinal side effects, including nausea, vomiting, abdominal pain, and diarrhea.79,80 Central nervous system symptoms, including agitation, restlessness, insomnia, tremors, dizziness, and confusion, have also been reported. In one case, confusion was severe enough to require hospitalization.79 These side effects were likely related to the caffeine in the green tea extract.80 In a 4-week clinical trial that assessed the safety of decaffeinated green tea extracts (800 mg/day of EGCG) in healthy individuals, a few of the participants reported mild nausea, stomach upset, dizziness, or muscle pain.81
The safety of tea extracts or supplements for pregnant or breast-feeding women has not been established. Some organizations advise pregnant women to limit their caffeine consumption to 300 mg/day, because higher caffeine intakes have been associated with increased risk of miscarriage and lower birth weight in some epidemiological studies. See Chapter 6 on coffee.
Excessive green tea consumption may decrease the therapeutic effects of the anticoagulant, warfarin (Coumadin). Such an effect was documented in one patient who began drinking one half gallon to one gallon of green tea daily.82 It is probably not necessary for people on warfarin therapy to avoid green tea entirely; however, large quantities of green tea may decrease warfarin's effectiveness.83
Several drugs can impair the metabolism of caffeine, increasing the potential for adverse effects from caffeine.84 Such drugs include cimetidine (Tagamet), disulfiram (Antabuse), estrogens, fluoroquinolone antibiotics (e.g., ciprofloxacin, enoxacin, norfloxacin), fluconazole (Diflucan), fluvoxamine (Luvox), mexiletine (Mexitil), riluzol (Rilutek), terbinafine (Lamisil), and verapamil (Calan). High caffeine intakes may increase the risk of toxicity of some drugs, including albuterol (Alupent), clozapine (Clozaril), ephedrine, epinephrine, monoamine oxidase inhibitors, phenylpropanolamine, and theophylline. Abrupt caffeine withdrawal has been found to increase serum lithium levels in people taking lithium, potentially increasing the risk of lithium toxicity. See Chapter 6 for more information on caffeine–drug interactions.
Flavonoids in tea can bind nonheme iron, inhibiting its intestinal absorption. Nonheme iron is the principal form of iron in plant foods, dairy products, and iron supplements. The consumption of one cup of tea with a meal has been found to decrease the absorption of nonheme iron in that meal by approximately 70%.85,86 To maximize iron absorption from a meal or iron supplements, tea should not be consumed at the same time.
• Tea is an infusion of the leaves of the Camellia sinensis plant, which is not to be confused with so-called herbal teas.
• Some biologically active chemicals in tea include flavonoids, caffeine, and fluoride.
• Overall, observational studies in humans suggest that daily consumption of at least three cups of tea may be associated with a modest (11%) decrease in the risk of myocardial infarction (heart attack).
• Despite promising results from animal studies, it is not clear whether increasing tea consumption will help prevent cancers in humans.
• Although tea consumption has been positively associated with bone density in some studies, it is not clear whether tea consumption reduces the risk of fractures due to osteoporosis.
• Limited research suggests that tea consumption may be associated with fewer cavities and a slightly lower risk of kidney stones, but more research is needed to confirm these findings.
• It is currently unclear whether tea or tea extracts promote weight loss. Large-scale clinical trials that control for energy intake and expenditure are needed to answer this question.
1. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21(3):334–350
2. Balentine DA, Paetau-Robinson I. Tea as a source of dietary antioxidants with a potential role in prevention of chronic diseases. In: Mazza G, Oomah BD, eds. Herbs, Botanicals, & Teas. Lancaster: Technomic Publishing Co., Inc.; 2000:265–287
3. Santana-Rios G, Orner GA, Amantana A, Provost C, Wu SY, Dashwood RH. Potent antimutagenic activity of white tea in comparison with green tea in the Salmonella assay. Mutat Res 2001;495(1–2):61–74
4. Lakenbrink C, Lapczynski S, Maiwald B, Engelhardt UH. Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages. J Agric Food Chem 2000;48(7):2848–2852
5. Astill C, Birch MR, Dacombe C, Humphrey PG, Martin PT. Factors affecting the caffeine and polyphenol contents of black and green tea infusions. J Agric Food Chem 2001;49(11):5340–5347
6. McCusker RR, Goldberger BA, Cone EJ. Caffeine content of specialty coffees. J Anal Toxicol 2003;27(7): 520–522
7. Lin JK, Lin CL, Liang YC, Lin-Shiau SY, Juan IM. Survey of catechins, gallic acid, and methylxanthines in green, oolong, pu-erh, and black teas. J Agric Food Chem 1998;46(9):3635–3642
8. Lin YS, Tsai YJ, Tsay JS, Lin JK. Factors affecting the levels of tea polyphenols and caffeine in tea leaves. J Agric Food Chem 2003;51(7):1864–1873
9. Wong MH, Fung KF, Carr HP. Aluminium and fluoride contents of tea, with emphasis on brick tea and their health implications. Toxicol Lett 2003;137(1–2):111–120
10. Cao J, Bai X, Zhao Y, et al. The relationship of fluorosis and brick tea drinking in Chinese Tibetans. Environ Health Perspect 1996;104(12):1340–1343
11. Cao J, Zhao Y, Liu J, et al. Brick tea fluoride as a main source of adult fluorosis. Food Chem Toxicol 2003;41(4):535–542
12. Fung KF, Zhang ZQ, Wong JWC, Wong MH. Fluoride contents in tea and soil from tea plantations and the release of fluoride into tea liquor during infusion. Environ Pollut 1999;104(2):197–205
13. Cao J, Luo SF, Liu JW, Li YH. Safety evaluation on fluoride content in black tea. Food Chem 2004;88(2):233–236
14. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001;154(6):495–503
15. Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002;75(5):880–886
16. Sesso HD, Gaziano JM, Liu S, Buring JE. Flavonoid in-take and the risk of cardiovascular disease in women. Am J Clin Nutr 2003;77(6):1400–1408
17. Sesso HD, Paffenbarger RS Jr, Oguma Y, Lee IM. Lack of association between tea and cardiovascular disease in college alumni. Int J Epidemiol 2003;32(4):527–533
18. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006;296(10):1255–1265
19. Vita JA. Tea consumption and cardiovascular disease: effects on endothelial function. J Nutr 2003; 133(10):3293S–3297S
20. Duffy SJ, Keaney JF Jr, Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001;104(2):151–156
21. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ. Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 2002; 102(2):195–201
22. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 2005; 81(1, Suppl):292S–297S
23. Nagaya N, Yamamoto H, Uematsu M, et al. Green tea reverses endothelial dysfunction in healthy smokers. Heart 2004;90(12):1485–1486
24. Kim W, Jeong MH, Cho SH, et al. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J 2006;70(8):1052–1057
25. Widlansky ME, Hamburg NM, Anter E, et al. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 2007;26(2):95–102
26. Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr 2003;133(10):3262S–3267S
27. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25–54
28. Lu YP, Lou YR, Lin Y, et al. Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res 2001;61(13):5002–5009
29. Chung FL, Wang M, Rivenson A, et al. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res 1998;58(18):4096–4101
30. Carter O, Dashwood RH, Wang R, et al. Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutr Cancer 2007;58(1):60–65
31. Williams RJ, Spencer JP, Rice-Evans C. Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 2004;36(7):838–849
32. Hou Z, Lambert JD, Chin KV, Yang CS. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention. Mutat Res 2004;555(1–2):3–19
33. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006;66(5):2500–2505
34. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003;43(1):89–143
35. Kono S, Ikeda M, Tokudome S, Kuratsme M. A case control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 1988;79:1067–1074
36. Setiawan VW, Zhang Zf, Yu GP, et al. Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int J Cancer 2001; 92:600–604
37. Yu GP, Hsieh CC, Wang LY, Yu St, Li XL, Jin TH. Green tea consumption and risk of stomach cancer: a population-based case control study in Shanghai, China. Cancer Causes Control 1995;6:532–538
38. Hoshiyama Y, Kawaguchi T, Miura Y, et al; Japan Collaborative Cohort Study Group. A nested case-control study of stomach cancer in relation to green tea consumption in Japan. Br J Cancer 2004;90(1):135–138
39. Koizumi Y, Tsubono Y, Nakaya N, et al. No association between green tea and the risk of gastric cancer: pooled analysis of two prospective studies in Japan. Cancer Epidemiol Biomarkers Prev 2003;12(5):472–473
40. Hoshiyama Y, Kawaguchi T, Miura Y, et al; Japan Collaborative Cohort Study Group. A prospective study of stomach cancer death in relation to green tea consumption in Japan. Br J Cancer 2002;87(3):309–313
41. Tsubono Y, Nishino Y, Komatsu S, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med 2001;344(9):632–636
42. Hoshiyama Y, Kawaguchi T, Miura Y, et al; JACC Study Group. Green tea and stomach cancer—a short review of prospective studies. J Epidemiol 2005;15(Suppl 2):S109–S112
43. Orner GA, Dashwood WM, Blum CA, Díaz GD, Li Q, Dashwood RH. Suppression of tumorigenesis in the Apc (min) mouse: down-regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 2003;24(2):263–267
44. Arab L, Il'yasova D. The epidemiology of tea consumption and colorectal cancer incidence. J Nutr 2003; 133(10):3310S–3318S
45. Tavani A, La Vecchia C. Coffee, decaffeinated coffee, tea and cancer of the colon and rectum: a review of epidemiological studies, 1990–2003. Cancer Causes Control 2004;15(8):743–757
46. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006;27(7):1301–1309
47. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 2009; (3):CD005004
48. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79(5):727–747
49. Wu AH, Tseng CC, Van Den Berg D, Yu MC. Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 2003;63(21):7526–7529
50. Wu CH, Yang YC, Yao WJ, Lu FH, Wu JS, Chang CJ. Epidemiological evidence of increased bone mineral density in habitual tea drinkers. Arch Intern Med 2002;162(9):1001–1006
51. Hernández-Avila M, Stampfer MJ, Ravnikar VA, et al. Caffeine and other predictors of bone density among pre- and perimenopausal women. Epidemiology 1993;4(2):128–134
52. Hegarty VM, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr 2000;71(4):1003–1007
53. Hoover PA, Webber CE, Beaumont LF, Blake JM. Postmenopausal bone mineral density: relationship to calcium intake, calcium absorption, residual estrogen, body composition, and physical activity. Can J Physiol Pharmacol 1996;74(8):911–917
54. Devine A, Hodgson JM, Dick IM, Prince RL. Tea drinking is associated with benefits on bone density in older women. Am J Clin Nutr 2007;86(4):1243–1247
55. Kanis J, Johnell O, Gullberg B, et al. Risk factors for hip fracture in men from southern Europe: the MEDOS study. Mediterranean Osteoporosis Study. Osteoporos Int 1999;9(1):45–54
56. Johnell O, Gullberg B, Kanis JA, et al. Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res 1995;10(11):1802–1815
57. Chen Z, Pettinger MB, Ritenbaugh C, et al. Habitual tea consumption and risk of osteoporosis: a prospective study in the women's health initiative observational cohort. Am J Epidemiol 2003;158(8):772–781
58. Hernandez-Avila M, Colditz GA, Stampfer MJ, Rosner B, Speizer FE, Willett WC. Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr 1991;54(1):157–163
59. Trevisanato SI, Kim YI. Tea and health. Nutr Rev 2000;58(1):1–10
60. Rasheed A, Haider M. Antibacterial activity of Camellia sinensis extracts against dental caries. Arch Pharm Res 1998;21(3):348–352
61. Matsumoto M, Minami T, Sasaki H, Sobue S, Hamada S, Ooshima T. Inhibitory effects of oolong tea extract on caries-inducing properties of mutans streptococci. Caries Res 1999;33(6):441–445
62. Hirasawa M, Takada K, Otake S. Inhibition of acid production in dental plaque bacteria by green tea catechins. Caries Res 2006;40(3):265–270
63. Linke HA, LeGeros RZ. Black tea extract and dental caries formation in hamsters. Int J Food Sci Nutr 2003;54(1):89–95
64. Jones C, Woods K, Whittle G, Worthington H, Taylor G. Sugar, drinks, deprivation and dental caries in 14-year-old children in the north west of England in 1995. Community Dent Health 1999;16(2):68–71
65. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med 1998;128(7):534–540
66. Curhan GC, Willett WC, Rimm EB, Spiegelman D, Stampfer MJ. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996; 143(3):240–247
67. Itoh Y, Yasui T, Okada A, Tozawa K, Hayashi Y, Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 2005;173(1):271–275
68. Borghi L, Meschi T, Schianchi T, et al. Urine volume: stone risk factor and preventive measure. Nephron 1999;81(Suppl 1):31–37
69. Massey LK, Roman-Smith H, Sutton RA. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones. J Am Diet Assoc 1993;93(8):901–906
70. Massey LK. Tea oxalate. Nutr Rev 2000;58(3 Pt 1):88–89
71. Komatsu T, Nakamori M, Komatsu K, et al. Oolong tea increases energy metabolism in Japanese females. J Med Invest 2003;50(3–4):170–175
72. Rumpler W, Seale J, Clevidence B, et al. Oolong tea increases metabolic rate and fat oxidation in men. J Nutr 2001;131(11):2848–2852
73. Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70(6):1040–1045
74. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of green tea on weight maintenance after body-weight loss. Br J Nutr 2004;91(3):431–437
75. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 2005;13(7):1195–1204
76. Nagao T, Komine Y, Soga S, et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 2005;81(1):122–129
77. Aizaki T, Osaka M, Hara H, et al. Hypokalemia with syncope caused by habitual drinking of oolong tea. Intern Med 1999;38(3):252–256
78. Trewby PN, Rutter MD, Earl UM, Sattar MA. Teapot myositis. Lancet 1998;351(9111):1248
79. Jatoi A, Ellison N, Burch PA, et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer 2003;97(6):1442–1446
80. Pisters KM, Newman RA, Coldman B, et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol 2001;19(6):1830–1838
81. Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multipledose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003;9(9):3312–3319
82. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother 1999;33(4):426–428
83. Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin. Am J Health Syst Pharm 2000;57(13):1221–1227, quiz 1228–1230
84. Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000;39(2):127–153
85. Hurrell RF, Reddy M, Cook JD. Inhibition of non-haem iron absorption in man by polyphenolic-containing beverages. Br J Nutr 1999;81(4):289–295
86. Zijp IM, Korver O, Tijburg LB. Effect of tea and other dietary factors on iron absorption. Crit Rev Food Sci Nutr 2000;40(5):371–398